Reference number : 236-2017-2018-Q4-00305, amendment number : , agreement type : G, recipient legal name : Sapp, John L, recipient country : CA, recipient province : NS, recipient city : Halifax, recipient postal code : B3H 2Y9, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 979200.0, agreement start date : 2018-04-01, agreement end date : 2024-03-31, description english : The VANISH2 Trial: Ventricular Tachycardia Antiarrhythmics or Ablation in Structural Heart Disease 2, description french : The VANISH2 Trial: Ventricular Tachycardia Antiarrhythmics or Ablation in Structural Heart Disease 2, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2018-19 to 2023-24), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2018-19 à 2023-24), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada